A Randomized, Double-Blind Phase 2 Trial Of The Cxcrii2 Inhibitor Ladarixin In Adult Patients With New-Onset Type 1 DiabetesEmanuele Bosi,Paolo Pozzilli,Francesco Giorgino,Efisio Cossu,Thomas Linn,Ludger Rose,Bart Keymeulen,Pieter Gillard,Luisa Daffonchio,Pier A. Ruffini,Marcello Allegretti,Lorenzo PiemontiDIABETES(2020)引用 2|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要